Why Integra Lifesciences Stock Is Sinking Today
Shares of Integra Lifesciences (NASDAQ: IART) were sinking 15.5% as of 11 a.m. ET on Monday. The decline came after the medical technology company announced its second-quarter results before the market opened.
Integra reported Q2 revenue of $418.2 million, up 9.7% year over year. This topped the average analyst revenue estimate of nearly $413.2 million.
The company posted a loss per share of $0.16, based on generally accepted accounting principles (GAAP). Integra announced adjusted earnings per share (EPS) of $0.63. Although this reflected a decline from adjusted EPS of $0.71 in the prior-year period, it narrowly beat the consensus estimate of $0.62.
Source Fool.com
Integra LifeSciences Holdings Corp Aktie
?
0,00 %
Die Community unterstützt Integra LifeSciences Holdings Corp nicht stark, mit mehr Sell- als Buy-Einschätzungen.
Ein prognostiziertes Kursziel von 9 € für Integra LifeSciences Holdings Corp zeigt ein Potenzial von über 20% Rückgang im Vergleich zum aktuellen Kurs von 15.4 €.
